Michael S. Weiss - Mar 12, 2023 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
CEO and President, Director
Signature
/s/ Michael S. Weiss
Stock symbol
TGTX
Transactions as of
Mar 12, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 05:00 PM
Previous filing
Feb 14, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX COMMON STOCK Award $0 +985K +8.96% $0.00 12M Mar 12, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.
F2 Includes shares of restricted Common Stock, which vest over various time periods.